🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Colgate-Palmolive executive sells $3.98m in stock

Published 02/08/2024, 21:08
CL
-

In a recent transaction, Panagiotis Tsourapas, Group President of Europe and Developing Markets at Colgate-Palmolive Co. (NYSE:CL), sold shares totaling approximately $3.98 million. The executive offloaded 40,000 shares at a weighted average price ranging from $99.295 to $99.585, with the transaction taking place on July 31, 2024.

The sale followed Tsourapas's exercise of options to acquire the same number of shares at $72.29 each, amounting to nearly $2.89 million. This transaction was part of the company's incentive compensation plan, indicating a strategic move within the executive's investment portfolio.

Following the sale, Tsourapas's direct holdings in Colgate-Palmolive decreased to 5,146 shares, not accounting for any indirect holdings he may have. The company, known for its range of consumer products including oral care, personal care, home care, and pet nutrition, has Tsourapas overseeing some of its most critical markets.

Investors often monitor insider transactions such as these for insights into executive confidence in the company's prospects. While the reasons for Tsourapas's sale were not disclosed, the transactions were carried out in compliance with regulatory requirements and with transparency regarding the prices achieved.

Colgate-Palmolive's stock activity can be followed under the ticker symbol NYSE:CL, and investors will be watching to see how these insider transactions may impact the stock's performance in the coming days.

In other recent news, Colgate-Palmolive has been experiencing robust growth, as demonstrated by its second quarter performance in 2024. The company reported a return to mid single-digit volume growth and expanding gross margins, largely credited to innovation, strategic marketing, and the application of data analytics and AI tools. Moreover, the Hill's business segment notably contributed to the company's market share gains.

Analysts have responded positively to these developments. TD Cowen has increased its price target on Colgate-Palmolive to $115 from the previous $110, maintaining a Buy rating, while revising its earnings per share growth estimate for the company upward to 11.1% from 10.5%. Jefferies, despite maintaining a Hold rating, increased the shares target of Colgate to $101 from $95, expressing caution regarding the sustainability of such performance. Evercore ISI, on the other hand, maintained an Outperform rating, raising the price target from $106 to $112, highlighting Colgate's strong growth prospects and high return on invested capital within the household and personal care industry.

Despite potential industry deceleration in Europe, Colgate-Palmolive maintained solid volume growth and plans to continue this trajectory with a consistent pricing and promotional strategy. The company also reported favorable volume growth in various markets, particularly in Brazil and Mexico. These are among the recent developments for the multinational consumer products company.

InvestingPro Insights

As Colgate-Palmolive Co. (NYSE:CL) remains in the spotlight following insider transactions, potential investors and current shareholders may find the following metrics and tips from InvestingPro valuable in assessing the company's financial health and stock performance.

InvestingPro data reveals that Colgate-Palmolive maintains a market capitalization of $83.76 billion, reflecting its significant presence in the consumer goods market. Furthermore, the company's P/E ratio stands at 29.59, with an adjusted P/E ratio for the last twelve months as of Q2 2024 at 28.76. This suggests that the company is trading at a valuation that takes into account its earnings capacity. The gross profit margin during the same period is notably high at 59.7%, underscoring Colgate-Palmolive's efficiency in managing production costs relative to its revenue.

Two InvestingPro Tips that stand out for Colgate-Palmolive include the company's impressive streak of raising its dividend for 34 consecutive years and its low price volatility. These factors indicate a stable investment for those seeking consistent returns and lower risk. Additionally, the company's ability to cover interest payments with its cash flows suggests a robust financial position, which can be reassuring for investors concerned about debt sustainability.

For those seeking further insights, InvestingPro offers a total of 13 additional tips for Colgate-Palmolive, accessible through their dedicated platform. This includes insights into analyst predictions, profitability, and trading multiples, which can be particularly useful for making informed investment decisions.

With Colgate-Palmolive's next earnings date scheduled for October 25, 2024, investors will be keen to see how these financial metrics and expert insights align with the company's reported performance and future outlook.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.